Jim Cramer Discusses These 12 Stocks & Trump DOJ’s Action Against Health Insurance Companies

10. Hims & Hers Health, Inc. (NYSE:HIMS)

Number of Hedge Fund Holders In Q4 2024: 38

Hims & Hers Health, Inc. (NYSE:HIMS) is a technology company that enables users to digitally avail health care services and access. It’s one of the top-performing stocks on Wall Street as the shares have gained 417% over the past year. Hims & Hers Health, Inc. (NYSE:HIMS)’s shares have benefited from several catalysts. These include the firm’s decision to include weight loss drugs in its portfolio and continued customer growth. However, the shares dropped by 26% in February after the FDA announced that the shortage of weight loss drugs was ending. The shortage end implied that the firm would be unable to charge high prices for the treatments. Here is what Cramer said about Hims & Hers Health, Inc. (NYSE:HIMS):

“Now HIMS by the way . . .they are adamant, let me put this really clear. That they’ve got waste that they can do compounding. So they’re not that worried, it is a big short squeeze by the way. And I don’t like to really recommend short squeezes other than Palantir! Palantir! You can’t go wrong with Palantir. You can mention, I have fifteen of my friends down at the [inaudible] on what was the stock that they owned? Palantir.”